US EditionMan Who Thought He Had Just Pulled a Muscle Given Four Months to Live
Sasse says an experimental drug has cut tumor volume by 76% as he describes accepting limited time and the toll on his family.
- In a New York Times interview published Thursday, former Nebraska Senator Ben Sasse discussed his metastatic Stage 4 pancreatic cancer diagnosis and the experimental treatment regimen he began following his December announcement.
- Sasse is participating in a clinical trial at MD Anderson Cancer Center using daraxonrasib, which he described as a "nasty drug" causing severe skin breakdown and bleeding that leaves his face feeling "nuclear."
- Tumor volume has decreased by 76% since starting treatment, and Sasse lowered his daily morphine intake from 55 milligrams to about 30 milligrams, demonstrating improved pain management.
- Reflecting on his family, Sasse admitted lingering "heaviness" about missing future milestones but emphasized finding peace through his Christian faith while remaining committed to fighting the disease.
- Beyond his diagnosis, Sasse criticized the American media and political environment, arguing that both parties increasingly rely on amplifying fringe behavior rather than solving substantive problems.
15 Articles
15 Articles
Former Senator Nearly Unrecognizable After Aggressive Cancer Is Destroying His Body
I have a really awful update to share with you. Former Senator Ben Sasse from Nebraska is one of those guys seemingly in the Thomas Massie / Rand Paul category of people. Seemingly very likeable in general. “Right” on most policies, at least in a vacuum. Seems like a really good guy at his core. But a pretty extreme anti-Trumper and never helped get any MAGA policies through Congress. Setting all of that aside, I wouldn’t want what he is going t…
What Happened To Ben Sasse's Face? Former Senator Reveals Bloody Skin From Experimental Pancreatic Cancer Drug
Former Nebraska Senator Ben Sasse has spoken candidly about the visible and painful side effects of the experimental drug he is taking for Stage 4 pancreatic cancer. In a New York Times interview published on 9 April 2026, the 54-year-old father of three detailed how daraxonrasib has caused his skin to break down, leaving his face bloody and feeling as if it has been exposed to nuclear forces. The treatment, part of a clinical trial, comes after…
Former lawmaker dying of cancer says Senate full of 'blowhards' when it should be greatest deliberative body | Fox Wilmington WSFX-TV
close Video Ben Sasse opens up about terminal cancer battle, faith and final months Former Sen. Ben Sasse reveals his Stage 4 cancer diagnosis, detailing his treatment, family reflections, and faith as he faces a limited life expectancy in a candid interview on “Interesting Times.” NEWYou can now listen to Fox News articles! Former Sen. Ben Sasse said in an interview Thursday that America’s political and media ecosystem has become a distracti…
Coverage Details
Bias Distribution
- 36% of the sources lean Left, 36% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
